Filing Details

Accession Number:
0001525587-12-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-13 16:07:03
Reporting Period:
2012-06-11
Filing Date:
2012-06-13
Accepted Time:
2012-06-13 16:07:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1311230 Solazyme Inc SZYM Industrial Organic Chemicals (2860) 331077078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514852 S Jonathan Wolfson Solazyme, Inc.
225 Gateway Boulevard
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-06-11 10,593 $12.48 3,241,949 No 4 S Indirect by Trust
Common Stock Disposition 2012-06-12 14,970 $12.47 3,226,979 No 4 S Indirect by Trust
Common Stock Disposition 2012-06-13 39,437 $12.48 3,187,542 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2011 and amended on December 9, 2011.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.53, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The Jonathan S. Wolfson Revocable Trust dated August 12, 2010.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.57, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.